Early-stage biotech developing an add-on therapy for epilepsy.
Industry: Health Care
First Day Return: 0.0%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 05/12/2014 |
Offer Price | $8.00 |
Price Range $12.00 - $14.00 | |
Offer Shares (mm) | 5.6 |
Deal Size ($mm) | $45 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 07/31/2014 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $45 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | New Haven, CT, United States |
Founded | 2003 |
Employees at IPO | 4 |
Website www.marinuspharma.com |